Does ROTIGOTINE Cause Application site vesicles? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Application site vesicles have been filed in association with ROTIGOTINE (Neupro). This represents 0.8% of all adverse event reports for ROTIGOTINE.
65
Reports of Application site vesicles with ROTIGOTINE
0.8%
of all ROTIGOTINE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Application site vesicles From ROTIGOTINE?
Of the 65 reports, 2 (3.1%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROTIGOTINE. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does ROTIGOTINE Cause?
Product adhesion issue (1,718)
Off label use (646)
Drug ineffective (632)
Death (595)
Parkinson's disease (419)
Fall (412)
Device adhesion issue (383)
Overdose (353)
Application site pruritus (334)
Application site erythema (330)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which ROTIGOTINE Alternatives Have Lower Application site vesicles Risk?
ROTIGOTINE vs ROXADUSTAT
ROTIGOTINE vs ROXICODONE
ROTIGOTINE vs ROXITHROMYCIN
ROTIGOTINE vs ROZANOLIXIZUMAB
ROTIGOTINE vs ROZANOLIXIZUMAB-NOLI